These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 8717259

  • 1. [The experimental study of myocardial protection for warm myocardial ischemia in an isolated rat heart: the effect of a calcium antagonist].
    Fukuhiro Y.
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):130-7. PubMed ID: 8717259
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
    Greenfield DT, Greenfield LJ, Hess ML.
    J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
    [Abstract] [Full Text] [Related]

  • 3. [Diltiazem abolishes the effect of ryanodine in St. Thomas' Hospital cardioplegic solution on the post-ischemic functional recovery].
    Yamamoto H, Ichikawa H, Yamamoto F.
    Nihon Kyobu Geka Gakkai Zasshi; 1995 Jan; 43(1):19-25. PubMed ID: 7884256
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of the protective prorerties of St. Thomas', Tyers', and Bretschneider's cardioplegic solutions in the neonatal rabbit heart].
    Murashita T, Yasuda K.
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2019-26. PubMed ID: 8958717
    [Abstract] [Full Text] [Related]

  • 5. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution.
    von Oppell UO, Du Toit EF, King LM, Owen P, Dunne T, Reichart B, Opie LH.
    J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179
    [Abstract] [Full Text] [Related]

  • 6. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R, Chambers DJ.
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [Abstract] [Full Text] [Related]

  • 7. [Effects of ischemic preconditioning on the recovery of myocardial function after unprotected ischemia and cardioplegia in the isolated and crystalloid perfused rat hearts].
    Otani H, Kawasaki H, Ninomiya H, Kido M, Kawaguchi H, Osako M, Kato Y, Imamura H.
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):23-30. PubMed ID: 9028119
    [Abstract] [Full Text] [Related]

  • 8. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution.
    Kinoshita K, Oe M, Tokunaga K.
    J Thorac Cardiovasc Surg; 1991 Apr; 101(4):695-702. PubMed ID: 2008108
    [Abstract] [Full Text] [Related]

  • 9. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Maruyama Y, Chambers DJ.
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603
    [Abstract] [Full Text] [Related]

  • 10. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
    Ledingham SJ, Braimbridge MV, Hearse DJ.
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
    [Abstract] [Full Text] [Related]

  • 11. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
    Chambers DJ, Takahashi A, Hearse DJ.
    J Heart Lung Transplant; 1992 Jan; 11(4 Pt 1):665-75. PubMed ID: 1498129
    [Abstract] [Full Text] [Related]

  • 12. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
    Kempsford RD, Hearse DJ.
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
    Karck M, Vivi A, Tassini M, Schwalb H, Askenasy N, Navon G, Borman JB, Uretzky G.
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
    Baker JE, Boerboom LE, Olinger GN.
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
    [Abstract] [Full Text] [Related]

  • 17. Protection of the ischemic immature heart--effect of perfusate reinfusion and composition.
    Baker JE, Olinger GN, Boerboom LE.
    Thorac Cardiovasc Surg; 1993 Oct; 41(5):274-9. PubMed ID: 8303694
    [Abstract] [Full Text] [Related]

  • 18. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS, Hearse DJ.
    Can J Cardiol; 1989 Oct; 5(8):401-7. PubMed ID: 2514036
    [Abstract] [Full Text] [Related]

  • 19. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
    Takahashi A, Chambers DJ, Braimbridge MV, Hearse DJ.
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.